• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管试验与登记数据统计分析新方法综述

Review of New Statistical Techniques for Analysis of Cardiovascular Trial and Registry Data.

作者信息

Amaratunga Dhammika, Cabrera Javier

机构信息

Rutgers Cardiovascular Institute, Rutgers University, Newark, NJ, USA.

出版信息

Curr Hypertens Rep. 2015 Oct;17(10):81. doi: 10.1007/s11906-015-0591-8.

DOI:10.1007/s11906-015-0591-8
PMID:26323874
Abstract

Cardiovascular research generates a large variety of data including big and small datasets that pose interesting challenges to researchers in biomedical statistics. This paper covers a number of important methodology issues and the solutions that have been applied so far to try to solve them. The first issue is multiple testing and the use of false discovery rates to correct for multiplicity. This is illustrated with an application related to genotyping heart diseases. The second is measuring life extension at present and in the future. The third one is the issue of U and J curves and the questions they present. Finally, this paper studies visit-to-visit blood pressure variability as a predictor of cardiovascular events.

摘要

心血管研究产生了各种各样的数据,包括大小数据集,这给生物医学统计学领域的研究人员带来了有趣的挑战。本文涵盖了一些重要的方法学问题以及目前为尝试解决这些问题而应用的解决方案。第一个问题是多重检验以及使用错误发现率来校正多重性。这通过一个与心脏病基因分型相关的应用进行了说明。第二个问题是测量当前和未来的寿命延长情况。第三个问题是U型和J型曲线的问题以及它们所带来的疑问。最后,本文研究了就诊间血压变异性作为心血管事件的预测指标。

相似文献

1
Review of New Statistical Techniques for Analysis of Cardiovascular Trial and Registry Data.心血管试验与登记数据统计分析新方法综述
Curr Hypertens Rep. 2015 Oct;17(10):81. doi: 10.1007/s11906-015-0591-8.
2
Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients.收缩压变异性是老年高血压患者心血管结局的重要预测指标。
J Hypertens. 2014 Mar;32(3):525-33. doi: 10.1097/HJH.0000000000000028.
3
Association of central and peripheral blood pressures with intermediate cardiovascular phenotypes.中心血压和外周血压与心血管中间表型的关联。
Hypertension. 2014 Jun;63(6):1148-53. doi: 10.1161/HYPERTENSIONAHA.114.03361. Epub 2014 Mar 24.
4
Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.马凡综合征的心血管特征及其与基因型的关系。
Verh K Acad Geneeskd Belg. 2009;71(6):335-71.
5
Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL.透析患者血压变异性与心血管事件的相关性研究:来自 FOSIDIAL 的新证据。
Hypertension. 2012 Aug;60(2):339-46. doi: 10.1161/HYPERTENSIONAHA.111.190397. Epub 2012 Jul 9.
6
May autonomic indices from cardiovascular variability help identify hypertension?自主神经指数能否帮助识别高血压?
J Hypertens. 2014 Feb;32(2):363-73. doi: 10.1097/HJH.0000000000000020.
7
8
Blood pressure variability and cardiovascular control mechanisms in hypertension.高血压中的血压变异性与心血管控制机制
Clin Sci (Lond). 2003 Nov;105(5):545-7. doi: 10.1042/CS20030256.
9
Circulating microRNAs and hypertension--from new insights into blood pressure regulation to biomarkers of cardiovascular risk.循环微小RNA与高血压——从血压调节的新见解到心血管风险生物标志物
Curr Opin Pharmacol. 2016 Apr;27:1-7. doi: 10.1016/j.coph.2015.12.002. Epub 2016 Jan 28.
10
Increased visit-to-visit blood pressure variability is associated with worse cardiovascular outcomes in low ejection fraction heart failure patients: Insights from the HEAAL study.访视间血压变异性增加与低射血分数心力衰竭患者更差的心血管结局相关:HEAAL研究的见解。
Int J Cardiol. 2015;187:183-9. doi: 10.1016/j.ijcard.2015.03.169. Epub 2015 Mar 17.

引用本文的文献

1
Use of advanced statistical techniques to predict all-cause mortality in the Systolic Blood Pressure Intervention Trial.在收缩压干预试验中使用先进统计技术预测全因死亡率。
Int J Cardiol Hypertens. 2020 Sep 19;7:100053. doi: 10.1016/j.ijchy.2020.100053. eCollection 2020 Dec.

本文引用的文献

1
Identifying common genetic variants in blood pressure due to polygenic pleiotropy with associated phenotypes.鉴定与相关表型相关的血压多基因多效性中的常见遗传变异。
Hypertension. 2014 Apr;63(4):819-26. doi: 10.1161/HYPERTENSIONAHA.113.02077. Epub 2014 Jan 6.
2
Visit-to-visit blood pressure variability and cardiovascular death in the Systolic Hypertension in the Elderly Program.老年收缩期高血压研究中的血压变异性与心血管死亡。
J Clin Hypertens (Greenwich). 2014 Jan;16(1):34-40. doi: 10.1111/jch.12230. Epub 2013 Dec 11.
3
Association between chlorthalidone treatment of systolic hypertension and long-term survival.
氯噻酮治疗收缩期高血压与长期生存的关系。
JAMA. 2011 Dec 21;306(23):2588-93. doi: 10.1001/jama.2011.1821.
4
Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy.非常高龄高血压合并冠心病患者的血压与预后:INVEST 子研究。
Am J Med. 2010 Aug;123(8):719-26. doi: 10.1016/j.amjmed.2010.02.014.
5
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.血压变异性、收缩压最大值和偶发性高血压的预后意义。
Lancet. 2010 Mar 13;375(9718):895-905. doi: 10.1016/S0140-6736(10)60308-X.
6
Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group.老年人高血压治疗中的钠减少与体重减轻:老年人非药物干预随机对照试验(TONE)。TONE协作研究组
JAMA. 1998 Mar 18;279(11):839-46. doi: 10.1001/jama.279.11.839.
7
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.老年单纯收缩期高血压患者抗高血压药物治疗预防卒中。老年收缩期高血压计划(SHEP)的最终结果。SHEP合作研究小组。
JAMA. 1991 Jun 26;265(24):3255-64.